1-2 of 2
Sherif Rezk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, C. Gregory Albers, Wen-Pin Chen, Joseph C. Carmichael, Jinah Chung, Ellen Richmond, L.M. Rodriguez, Eva Szabo, Leslie G. Ford, Michael N. Pollak, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (2): 203–212.
https://doi.org/10.1158/1940-6207.CAPR-18-0262
Published: 05 February 2020
View article titled, A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Open the PDF for A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index in another window
Includes: Supplementary data
Journal Articles

Abstract A21: A Phase IIa trial of metformin for colorectal cancer risk reduction among patients with a history of colorectal adenomas and elevated body mass index

Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, Gregory C. Albers, Wen-Pin Chen, Joseph C. Carmichael, Luz Rodriguez, Eva Szabo, Leslie Ford, Michael Pollak, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (10_Supplement): A21.
https://doi.org/10.1158/1940-6215.PREV-14-A21
Published: 02 October 2015
View article titled, Abstract A21: A Phase IIa trial of metformin for colorectal cancer risk reduction among patients with a history of colorectal adenomas and elevated body mass index